Safety Concerns Over Immunosuppression In Ocular Surface Disease May Be Misplaced

Monday, April 12, 2010

Comments

Ocular Surgery News

BOSTON — Use of immunosuppression in conjunction with surgical management of severe ocular surface disease is safe and effective, according to a speaker.

Full Story

Corneal and Refractive Diagnostics »

A 45 y.o. female comes to the office with a chief complaint of tearing ou and foreign body sensation. Of note are small superficial punctate epitheliopathy diffusely over the central cornea. Her tear film is scanty ou. One would expect her Schirmer’s test
1. >15mm with anesthetic
2. < 10mm="" with="" />
3. >20mm without anesthetic
4. <5mm without="">
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Safety Concerns Over Immunosuppression In Ocular Surface Disease May Be Misplaced

Comments

Related Categories

Corneal and Refractive Diagnostics »

Quick Quiz

A 45 y.o. female comes to the office with a chief complaint of tearing ou and foreign body sensation. Of note are small superficial punctate epitheliopathy diffusely over the central cornea. Her tear film is scanty ou. One would expect her Schirmer’s test

AdGlare RMR Ad

Featured Products

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

3nethra classic Ophthalmic Imaging Device

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us